BME startup company’s initial product addresses chronic tendon pain.
A startup business born in the Master of Biomedical Innovation and Development (MBID) program at the Georgia Institute of Technology recently secured some investment support from the National Football League Players Association (NFLPA).
TendoNova, an Atlanta-based company that develops medical devices that enable microinvasive orthopedic procedures, emerged from the intensive Master’s program within the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory, and in 2019 was one of the finalists in the NFL’s 1st and Future Competition at Super Bowl LIII, held in Atlanta (Feb. 2019).
